Correlation Between Cumberland Pharmaceuticals and Boston Omaha

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cumberland Pharmaceuticals and Boston Omaha at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cumberland Pharmaceuticals and Boston Omaha into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cumberland Pharmaceuticals and Boston Omaha Corp, you can compare the effects of market volatilities on Cumberland Pharmaceuticals and Boston Omaha and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cumberland Pharmaceuticals with a short position of Boston Omaha. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cumberland Pharmaceuticals and Boston Omaha.

Diversification Opportunities for Cumberland Pharmaceuticals and Boston Omaha

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cumberland and Boston is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Cumberland Pharmaceuticals and Boston Omaha Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Boston Omaha Corp and Cumberland Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cumberland Pharmaceuticals are associated (or correlated) with Boston Omaha. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Boston Omaha Corp has no effect on the direction of Cumberland Pharmaceuticals i.e., Cumberland Pharmaceuticals and Boston Omaha go up and down completely randomly.

Pair Corralation between Cumberland Pharmaceuticals and Boston Omaha

Given the investment horizon of 90 days Cumberland Pharmaceuticals is expected to generate 1.94 times more return on investment than Boston Omaha. However, Cumberland Pharmaceuticals is 1.94 times more volatile than Boston Omaha Corp. It trades about 0.0 of its potential returns per unit of risk. Boston Omaha Corp is currently generating about -0.05 per unit of risk. If you would invest  215.00  in Cumberland Pharmaceuticals on September 3, 2024 and sell it today you would lose (75.00) from holding Cumberland Pharmaceuticals or give up 34.88% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cumberland Pharmaceuticals  vs.  Boston Omaha Corp

 Performance 
       Timeline  
Cumberland Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cumberland Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward indicators, Cumberland Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Boston Omaha Corp 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Boston Omaha Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Boston Omaha may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Cumberland Pharmaceuticals and Boston Omaha Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cumberland Pharmaceuticals and Boston Omaha

The main advantage of trading using opposite Cumberland Pharmaceuticals and Boston Omaha positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cumberland Pharmaceuticals position performs unexpectedly, Boston Omaha can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boston Omaha will offset losses from the drop in Boston Omaha's long position.
The idea behind Cumberland Pharmaceuticals and Boston Omaha Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges